Search is Powered by Google
Cancer / Oncology News

Cancer-Causing Role Of Gene Proteins Discovered By Scientists

Main Category: Cancer / Oncology
Also Included In: Genetics;  Breast Cancer
Article Date: 19 Sep 2008 - 6:00 PDT

email icon email to a friend   printer icon printer friendly   write icon view / write opinions   rate icon rate article
Current Article Ratings:

Patient / Public:not yet rated

Health Professional:not yet rated

Article Opinions: 0 posts

Dr. Tak Mak and scientists at The Campbell Family Institute for Breast Cancer Research at Princess Margaret Hospital have discovered the role of two "cousins" in the genetic family tree of cancer development.

The findings, published online in the journal Genes and Development, plant the seed for a critical new branch of scientific inquiry, says Dr. Mak, principal investigator. Dr. Mak, Director of The Campbell Family Institute is also a Professor, University of Toronto, in the Departments of Medical Biophysics and Immunology.

The cousins are proteins related to the gene p53 family - the patriarch known for two decades to be the master gatekeeper that controls all cancer development. When gene p53 is defective, it loses its ability to regulate healthy cells and suppress cancer.

"Until now, we thought these cousins (TAp73 protein isoforms) were not involved in cancer. Our results prove that they are. This is fundamental to understanding every human cancer and furthering the science."

In the lab, Dr. Mak and his team challenged traditional thinking about the role of these proteins. "Before, scientists studied only whether these proteins were present or absent. We decided to study how they interact with each other and discovered that they actually have a split personality. When we turn one 'on' or 'off', the other changes behavior and becomes part of the cancer-causing process. The key is understanding the ratio of the interaction."

"The next step is to understand how the ratio affects cell division that leads to human cancer," says Dr. Mak, whose work was supported by the Canadian Institutes for Health Research.

----------------------------
Article adapted by Medical News Today from original press release.
----------------------------

About Dr. Tak Mak

Dr. Tak Mak is a pre-eminent Canadian scientist and internationally acclaimed immunologist, renowned for his 1984 discovery of cloning the human T-cell receptor. His discoveries have made an enormous contribution to the understanding of immunity and especially as it relates to cancer and HIV/AIDS. Dr. Mak, Director of The Campbell Family Institute for Breast Cancer Research at Princess Margaret Hospital, University Health Network, has published more than 600 articles and received more than 3,000 citations in leading scientific journals. He is also Professor, University of Toronto, in the Departments of Medical Biophysics and Immunology.

His honours include the Gairdner Foundation International Award, the Emil von Behring Prize, the E.W.R Steacie Prize, and the General Motors Research Foundation Alfred P. Sloan Prize. Dr. Mak is an Officer of the Order of Canada, a Member of the Order of Ontario and recipient of the Premier's Summit Award, and a Fellow of the Royal Society of Canada and the Royal Society of London.

About The Campbell Family Institute for Breast Cancer Research

The Campbell Family Institute for Breast Cancer Research at Princess Margaret Hospital brings together an elite team of cancer researchers, scientists, clinicians and staff dedicated to the ultimate goal of conquering breast cancer by leveraging basic, translational and clinical research into dramatic breast cancer breakthroughs. http://www.campbellfamilyinstitute.com/

About Princess Margaret Hospital

Princess Margaret Hospital and its research arm Ontario Cancer Institute -- which includes The Campbell Family Cancer Research Institute and The Campbell Family Institute for Breast Cancer Research -- have achieved an international reputation as global leaders in the fight against cancer. Princess Margaret Hospital is a member of University Health Network, which also includes Toronto General Hospital and Toronto Western Hospital. All three are research hospitals affiliated with the University of Toronto. http://www.uhn.on.ca/

About University of Toronto

Established in 1827, the University of Toronto is Canada's largest and most influential university with almost 12,000 faculty and staff working at three campuses and ten academic hospitals in the Toronto region. Our world-leading scholars teach more than 60,000 students in 841 distinct undergraduate programs as well as 520 graduate and 42 professional programs. According to Thomson ISI data, U of T faculty also publish more research than any other publicly-funded university in North America. And with over 400,000 alumni in more than 130 countries around the world, U of T is truly global in reach and impact. http://www.utoronto.ca/

Source: Jane Finlayson
University of Toronto




Customized Homepage Weekly Newsletters Daily News Alerts
Home About Us News Licensing Free Website Feeds Free Tools & Content Links Tell a Friend Accessibility Help / FAQ Article Submission Contact Us
Urology
ADHD Autism Diabetes

add medical news today to your facebook

medical news gadget

Add to Google


developers
website gadget code
website news code
medical news rss feed links


customize your homepage


These are the most read articles from this news category for the last 6 months:
Top Article Star
Shocking Pictures To Appear On Cigarette Packets In UK On 1st October
27 Sep 2008
The UK's ten million Smokers may see pictures of rotting teeth, throat cancer, and indications of male impotence (erectile dysfunction) on cigarette packets they buy at the beginning of October...


Monitoring and Adherence in CML image Monitoring and Adherence in CML

Imatinib, or Gleevec, is a targeted anti-cancer drug that can keep chronic myelogenous leukemia (CML) in check for most patients for many years. It is important for patients to take imatinib as prescribed by their doctor to fight the disease and to guard against resistance...

Treating HER2+ Breast Cancer image Treating HER2+ Breast Cancer

There are at least four different kinds of breast cancer and each is treated differently. For HER2+ breast cancer, a chemotherapy drug is typically the best option. Here's an overview of the drugs used to treat breast cancer...

View more videos...